CompaniesCorat Therapeutics
Corat Therapeutics logo

Corat Therapeutics

active
Braunschweig, Germany
Founded 2020
Website
About

Recombinant Human Antibodies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

45

By Phase

PHASE1/PHASE2: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
Today
NCT04674566
Hover over trial bars to see details

Recent Trials

NCT04674566Lead Sponsor
Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19
PHASE1/PHASE2Unknown
45 participants
Started: Apr 21, 2021 · Completed: Oct 30, 2022
Locations (1)
Headquarters
Braunschweig, Germany
Map

Loading map...